Category: General

Providers Raise Caution on Claims Data Submission Requirements After 340B ESP Terms of Use Update Continues to Defer to Manufacturers

October 16, 2024 Shannon Young, Associate Editor/Senior Writer Views

Second Sight Solutions updated 340B ESP's terms of use on Oct. 4.

Editor’s Note: An earlier version of this story incorrectly suggested that an Oct. 4 update to 340B ESP’s terms of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Health Centers Urge Federal Appeals Court to Take Their Side in Case Alleging Drug Manufacturer Collusion on Contract Pharmacy Restrictions

October 16, 2024 Bella Czajkowski, National Correspondent Views

Two community health centers argued in a Sept. 30 filing with the U.S. 2nd Circuit Court of Appeals that diabetes drugmakers colluded to place contract pharmacy restrictions.

Two community health centers urged a federal appeals court to overturn the dismissal of their 340B antitrust lawsuit, arguing in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Weekly Roundup: Orders and Filings in Arkansas, Louisiana, Kansas, Mississippi Maryland, Missouri

October 10, 2024 Shannon Young, William Newton and Bella Czajkowski, Associate Editor/Senior Writer Views

Key motions were filed this week in state contract pharmacy litigation in Arkansas, Maryland, Louisiana, Kansas, Missouri, Minnesota and Mississippi.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Head of Drug Industry-Funded Think Tank Backs J&J’s Proposed Rebate Model, Slams Hospitals in Op-Ed

October 10, 2024 Shannon Young, Associate Editor/Senior Writer Views

Sally Pipes, the president and CEO of the drug-industry funded Pacific Research Institute, criticized pushback that led Johnson & Johnson to forgo its plans to implement a 340B rebate model in an Oct. 7 Forbes op-ed.

The leader of a right-leaning think tank that’s received funding from the drug industry criticized pushback that led Johnson & [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GSK Announces Specialty Pharmacy Senderra No Longer Eligible to Dispense Asthma Drug

October 8, 2024 Bella Czajkowski, National Correspondent Views

Senderra Rx will no longer dispense GlaxoSmithKline’s asthma drug, Nucala.

Specialty pharmacy Senderra Rx will no longer dispense GlaxoSmithKline’s (GSK’s) asthma treatment Nucala, the drug manufacturer announced on industry vendor [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Amgen Announces NDC Change for Osteoporosis Drug

October 8, 2024 Bella Czajkowski, National Correspondent Views

Amgen announced a change to the national drug code for its osteoporosis drug, Prolia.

Drugmaker Amgen announced a change to the national drug code (NDC) for its osteoporosis drug, Prolia. The California-based drug giant [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Lawmakers Hit Campaign Trail Without Unveiling Highly Anticipated SUSTAIN 340B Act

September 26, 2024 Shannon Young, Associate Editor/Senior Writer Views

The “Group of Six” is expected to announce this week that it plans to release the SUSTAIN Act by the end of the year.

Members of Congress are headed back to their districts this week to campaign ahead of the November elections without unveiling [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Editor’s Note: This article is available to all and is not behind the paywall. The first episode of 340B Report’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Category: General

Providers Raise Caution on Claims Data Submission Requirements After 340B ESP Terms of Use Update Continues to Defer to Manufacturers

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Health Centers Urge Federal Appeals Court to Take Their Side in Case Alleging Drug Manufacturer Collusion on Contract Pharmacy Restrictions

Please Login or Become a Paid Subscriber to View this Content

If you are already a

State Contract Pharmacy Lawsuit Weekly Roundup: Orders and Filings in Arkansas, Louisiana, Kansas, Mississippi Maryland, Missouri

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Head of Drug Industry-Funded Think Tank Backs J&J’s Proposed Rebate Model, Slams Hospitals in Op-Ed

Please Login or Become a Paid Subscriber to View this Content

If you are already a

GSK Announces Specialty Pharmacy Senderra No Longer Eligible to Dispense Asthma Drug

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Amgen Announces NDC Change for Osteoporosis Drug

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Lawmakers Hit Campaign Trail Without Unveiling Highly Anticipated SUSTAIN 340B Act

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Consolidated Service Centers and 340B: Can they Coexist?

7 Tips to Help Covered Entities Navigate ACA Open Enrollment

340B Report Kicks Off Editorial Roundtable Podcast and YouTube Show

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live